Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
Dr. Richard brings experience in running large-scale Parkinson’s trials and is familiar with the challenges facing this research area. Formalizing her role as advisor to the Foundation will help ensure that MJFF’s increasing involvement in clinical trials, including trial design and regulatory issues, is as efficient and targeted as possible. She will also provide important feedback on pre-clinical experimental design, helping to ensure that all studies funded by MJFF — not only those requiring the active involvement of patients — are designed with potential clinical issues in mind.
“Irene’s clinical research perspective complements the scientific expertise of Gene Johnson, PhD, MJFF’s chief scientific advisor, and her input will be a boon to our research staff and advisors in continually raising the bar on the patient-relevant outcomes we expect from every project we fund,” said Katie Hood, interim CEO of The Michael J. Fox Foundation. “Additionally, as a clinician with an active neurology practice, Irene has a deep understanding of the challenges faced every day by people living with PD — something the Foundation values deeply, since patients are at the center of every activity we undertake.”
Dr. Richard has served on the Foundation’s
“As a grant reviewer for the Foundation and a member of its Scientific Advisory Board, I’ve been impressed by The Michael J. Fox Foundation’s extraordinary commitment to speeding scientific solutions to the clinic and patients — a commitment I share,” said Dr. Richard. “The Foundation understands that it’s never too early in the drug development process to think clinically, and I’m thrilled to take on formal responsibility for working with its staff and advisors to continually improve our ability to do this across the board.